Rovatirelin Uses, Dosage, Side Effects and more
Rovatirelin is under investigation in clinical trial NCT01384435 (A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)).
| Trade Name | Rovatirelin |
| Generic | Rovatirelin |
| Rovatirelin Other Names | Rovatirelin |
| Type | |
| Formula | C16H22N4O4S |
| Weight | Average: 366.44 Monoisotopic: 366.136176378 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
